WIPO Promotes IP Flexibilities Database 05/05/2017 by Intellectual Property Watch Leave a Comment The UN World Intellectual Property Organization this week promoted a database it has developed containing a collection of flexibilities to IP laws in countries around the world.
WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 by Catherine Saez, Intellectual Property Watch 6 Comments A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided.
WHO Project To Prequalify Biosimilar Cancer Medicines Aims At Increased Affordability 04/05/2017 by Intellectual Property Watch 1 Comment The World Health Organization announced today that it will launch a pilot project in 2017 for prequalifying cancer biosimilar medicines, with the intent of lowering prices on some of the most expensive cancer treatments.
New Open Source Project Enlists Students To Find Cures For Neglected Diseases 03/05/2017 by Intellectual Property Watch 1 Comment The Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, United Kingdom, and the United States to help with the research on a debilitating neglected disease.
Enlisting Government Help To Protect Your Trade Secrets 03/05/2017 by Guest contributor for Intellectual Property Watch 1 Comment “I’m from the government and I’m here to help.” Yeah, right. Most businesses think protecting their intellectual property is their own responsibility, and it is. But what about when your intellectual property rights are violated by an evildoer? Who are you going to call?
New R&D Funding Model For TB, Antimicrobial Resistance 01/05/2017 by Intellectual Property Watch 3 Comments The World Health Organization Bulletin this month has an article about the need for new models of research and development for tuberculosis and antimicrobial resistance. The article describes a new funding framework called the 3P Project.
Real IP Issues Surface In A Virtual World 01/05/2017 by Dugie Standeford for Intellectual Property Watch Leave a Comment As virtual reality (VR) and augmented reality (AR) technologies emerge, so do legal questions arising from their use. While the issues are still mostly hypothetical, they implicate, among other areas, intellectual property rights, lawyers say.
The Global Debate On IP, Trade And Development: Past, Present and Future 29/04/2017 by Guest contributor for Intellectual Property Watch 1 Comment Register Now for The Global Debate on Intellectual Property, Trade and Development: Past, Present and Future – A Conference in Honour of Pedro Roffe, taking place on 15 June at the University of Geneva, Uni-Bastions, Geneva, Switzerland. Registration is open and free, see details.
TRIPS Flexibilities Under Threat From Investment Disputes: A Closer Look At Canada’s “Win” Against Eli Lilly 27/04/2017 by Intellectual Property Watch 3 Comments Cynthia Ho writes: In the first known investment dispute regarding patents, Eli Lilly & Co v. Canada, Canada recently prevailed over the pharmaceutical giant Eli Lilly. Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
WTO IP Division Director’s Thoughts On World IP Day 26/04/2017 by William New, Intellectual Property Watch 1 Comment Antony Taubman, director of the World Trade Organization Intellectual Property Division, has been in a good position to view the world and intellectual property for some time. Today, designated as World IP Day, we caught up with him to ask his views on the theme this year.